Eaton Vance Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Eaton Vance Management’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$61.5M	Buy	307,288 +537	+0.2%	+$102K	0.09%	219
2022 Q2	$44.7M	Buy	306,751 +523	+0.2%	+$74.2K	0.06%	288
2022 Q1	$50M	Buy	306,228 +262,893	+607%	+$40.1M	0.06%	306
2021 Q4	$7.35M	Sell	43,335 -674	-2%	-$125K	0.01%	688
2021 Q3	$8.29M	Buy	44,009 +2,518	+6%	+$472K	0.01%	602
2021 Q2	$7.03M	Sell	41,491 -4,378	-10%	-$641K	0.01%	685
2021 Q1	$6.48M	Sell	45,869 -103,799	-69%	-$15.6M	0.01%	671
2020 Q4	$19.5M	Sell	149,668 -64,315	-30%	-$8.59M	0.03%	423
2020 Q3	$31.2M	Sell	213,983 -6,743	-3%	-$958K	0.06%	286
2020 Q2	$32.7M	Buy	220,726 +112	+0.1%	+$15.1K	0.07%	254
2020 Q1	$24M	Buy	220,614 +34	+0%	+$3.92K	0.06%	269
2019 Q4	$25.4M	Sell	220,580 -24	-0%	-$2.39K	0.05%	289
2019 Q3	$17.7M	Hold	220,604	–	–	0.04%	338
2019 Q2	$16M	Sell	220,604 -131,129	-37%	-$10.1M	0.04%	345
2019 Q1	$32.9M	Buy	351,733 +313,942	+831%	+$26.3M	0.08%	238
2018 Q4	$2.75M	Hold	37,791	–	–	0.01%	637
2018 Q3	$3.31M	Hold	37,791	–	–	0.01%	632
2018 Q2	$3.72M	Sell	37,791 -35,841	-49%	-$3.55M	0.01%	584
2018 Q1	$8.77M	Buy	73,632 +36,766	+100%	+$4.74M	0.01%	537
2017 Q4	$4.68M	Buy	36,866 +5,000	+16%	+$628K	0.01%	533
2017 Q3	$3.74M	Sell	31,866 -83	-0.3%	-$7.08K	0.01%	552
2017 Q2	$2.55M	Hold	31,949	–	–	0.01%	621
2017 Q1	$1.64M	Sell	31,949 -100	-0.3%	-$4.62K	﹤0.01%	679
2016 Q4	$1.2M	Buy	32,049 +50	+0.2%	+$2.09K	﹤0.01%	694
2016 Q3	$2.17M	Hold	31,999	–	–	0.01%	571
2016 Q2	$1.78M	Sell	31,999 -100	-0.3%	-$6.3K	0.01%	582
2016 Q1	$2.02M	Buy	32,099 +200	+0.6%	+$13.3K	0.01%	550
2015 Q4	$3M	Sell	31,899 -100	-0.3%	-$9.27K	0.01%	489
2015 Q3	$2.57M	Hold	31,999	–	–	0.01%	505
2015 Q2	$3.84M	Buy	31,999 +21,600	+208%	+$2.58M	0.01%	436
2015 Q1	$1.09M	Buy	10,399 +75	+0.7%	+$7.6K	﹤0.01%	665
2014 Q4	$1M	Buy	+10,324	New	+$956K	﹤0.01%	660